1. Home
  2. ARMP vs LEE Comparison

ARMP vs LEE Comparison

Compare ARMP & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMP
  • LEE
  • Stock Information
  • Founded
  • ARMP N/A
  • LEE 1890
  • Country
  • ARMP United States
  • LEE United States
  • Employees
  • ARMP N/A
  • LEE N/A
  • Industry
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • LEE Newspapers/Magazines
  • Sector
  • ARMP Health Care
  • LEE Consumer Discretionary
  • Exchange
  • ARMP Nasdaq
  • LEE Nasdaq
  • Market Cap
  • ARMP 52.1M
  • LEE 52.4M
  • IPO Year
  • ARMP N/A
  • LEE N/A
  • Fundamental
  • Price
  • ARMP $1.95
  • LEE $6.15
  • Analyst Decision
  • ARMP Strong Buy
  • LEE
  • Analyst Count
  • ARMP 1
  • LEE 0
  • Target Price
  • ARMP $9.00
  • LEE N/A
  • AVG Volume (30 Days)
  • ARMP 624.1K
  • LEE 14.9K
  • Earning Date
  • ARMP 05-14-2025
  • LEE 05-08-2025
  • Dividend Yield
  • ARMP N/A
  • LEE N/A
  • EPS Growth
  • ARMP N/A
  • LEE N/A
  • EPS
  • ARMP N/A
  • LEE N/A
  • Revenue
  • ARMP $4,699,000.00
  • LEE $591,094,000.00
  • Revenue This Year
  • ARMP $8.43
  • LEE N/A
  • Revenue Next Year
  • ARMP N/A
  • LEE N/A
  • P/E Ratio
  • ARMP N/A
  • LEE N/A
  • Revenue Growth
  • ARMP 14.24
  • LEE N/A
  • 52 Week Low
  • ARMP $0.90
  • LEE $6.15
  • 52 Week High
  • ARMP $3.42
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • ARMP 56.79
  • LEE 24.19
  • Support Level
  • ARMP $1.74
  • LEE $6.50
  • Resistance Level
  • ARMP $2.20
  • LEE $6.97
  • Average True Range (ATR)
  • ARMP 0.32
  • LEE 0.31
  • MACD
  • ARMP 0.04
  • LEE -0.06
  • Stochastic Oscillator
  • ARMP 50.32
  • LEE 0.05

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: